InsiderTrades

Form 4 for MLYS Mineralys Therapeutics, Inc.

Accepted 2026-07-10 19:15:22 ET · period of report 2026-07-09 · accession 0001672659-26-000033 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2026-07-10 19:15 2026-07-09 MLYS Rodman David Malcom Chief Medical Off M - OptEx $16.00 +2,171 59.9K +4% +$34.7K
DT 2026-07-10 19:15 2026-07-09 MLYS Rodman David Malcom Chief Medical Off S - Sale+OE $30.30 -2,171 57.7K -4% -$65.8K
DT 2026-07-10 19:15 2026-07-09 MLYS Rodman David Malcom Chief Medical Off M - OptEx $0.00 -2,171 15.2K -13% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-07-09 M A 2,171 $16.00 59,904 D — — (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025. (F2) This balance includes 638 shares purchased under the Mineralys Therapeutics, Inc. 2023 Employee Stock Purchase Plan that were not previously reported.
2 Common Common Stock 2026-07-09 S D 2,171 $30.30 57,733 D — — (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.
3 Derivative Stock Option 2026-07-09 M D 2,171 $0.00 15,194 D $16.00 · — to 2033-02-09 2,171 Common Stock (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025. (F3) The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.